InsiderTrades

Form 4 for ISRG Intuitive Surgical

Accepted 2025-10-27 00:00:00 ET · period of report 2025-10-24 · accession 0001519593-25-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-10-27 2025-10-24 ISRG Rosa David J. CEO (CEO), Dir S - Sale+OE $547.55 -24.5K 234.3K -9% -$13.41M
D 2025-10-27 2025-10-24 ISRG Rosa David J. CEO (CEO), Dir M - OptEx $79.64 +27.0K 258.8K +12% +$2.15M
D 2025-10-27 2025-10-24 ISRG Rosa David J. CEO (CEO), Dir M - OptEx $0.00 -27.0K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-10-24 S D 24,500 $547.55 234,256 D — — (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $542.16 to $550.21 as follows: 1,075 shares sold at $542.16 to $543.10; 1,000 shares sold at $543.23 to $544.22; 1,830 shares sold at $544.30 to $545.06; 1,300 shares sold at $545.33 to $546.15; 2,346 shares sold at $546.34 to $547.30; 6,919 shares sold at $547.37 to $548.37; 7,257 shares sold at $548.40 to $549.40; and 2,773 shares sold at $549.42 to $550.21. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
2 Common Common Stock 2025-10-24 M A 27,000 $79.64 258,756 D — —
3 Derivative Non-Qualified Stock Option (right to buy) 2025-10-24 M D 27,000 $0.00 0 D $79.64 · — to 2027-02-15 27,000 Common Stock (F3) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.